1. Home
  2. ATRC
  3. ATRC News

Latest AtriCure Inc. (ATRC) News on April 3, 2025

ATRC

MT Newswires

6 days ago

Canaccord Genuity Adjusts Price Target on AtriCure to $52 From $66, Maintains Buy Rating

AtriCure to Host Analyst & Investor Day on March 26, 2025
ATRC

Business Wire

22 days ago

AtriCure to Host Analyst & Investor Day on March 26, 2025

AtriCure Full Year 2024 Earnings: EPS Misses Expectations
ATRC

Simply Wall St.

2 months ago

AtriCure Full Year 2024 Earnings: EPS Misses Expectations

AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know
ATRC

Zacks

2 months ago

AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know

ATRC

Thomson Reuters StreetEvents

2 months ago

Q4 2024 AtriCure Inc Earnings Call

ATRC

MT Newswires

2 months ago

Oppenheimer Adjusts AtriCure Price Target to $45 From $36, Maintains Outperform Rating

Is AnaptysBio (ANAB) Stock Outpacing Its Medical Peers This Year?
ATRC

Zacks

2 months ago

Is AnaptysBio (ANAB) Stock Outpacing Its Medical Peers This Year?

AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
ATRC

GuruFocus.com

2 months ago

AtriCure Inc (ATRC) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

ATRC

MT Newswires

2 months ago

AtriCure Q4 Adjusted Loss Narrows, Revenue Rises; 2025 Outlook Issued

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings
ATRC

Zacks

2 months ago

Here's What Key Metrics Tell Us About AtriCure (ATRC) Q4 Earnings

AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates
ATRC

Zacks

2 months ago

AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates

ATRC

Associated Press Finance

2 months ago

AtriCure: Q4 Earnings Snapshot

AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results
ATRC

Business Wire

2 months ago

AtriCure Reports Fourth Quarter 2024 and Full Year 2024 Financial Results

Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS
ATRC

Zacks

2 months ago

Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS

Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline
ATRC

Zacks

2 months ago

Earnings Preview: Bio-Rad Laboratories (BIO) Q4 Earnings Expected to Decline

Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know
ATRC

Zacks

2 months ago

Will AtriCure (ATRC) Report Negative Earnings Next Week? What You Should Know

Why AtriCure, Inc. (ATRC) Is Skyrocketing Now
ATRC

Insider Monkey

2 months ago

Why AtriCure, Inc. (ATRC) Is Skyrocketing Now

AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results
ATRC

Business Wire

2 months ago

AtriCure to Announce Fourth Quarter and Full Year 2024 Financial Results

Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last?
ATRC

Zacks

2 months ago

Brainsway (BWAY) Moves 8.0% Higher: Will This Strength Last?

ATRC

MT Newswires

3 months ago

AtriCure Shares Rise After Higher Q4, 2024 Revenue Projections; 2025 Revenue Outlook Set

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day
ATRC

Business Wire

3 months ago

AtriCure Reports Preliminary Results for Fourth Quarter and Full Year 2024, Provides Financial Outlook for 2025, and Announces Upcoming Analyst & Investor Day

AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
ATRC

Business Wire

3 months ago

AtriCure to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

AtriCure, Inc. (NASDAQ:ATRC) Shares Could Be 26% Below Their Intrinsic Value Estimate
ATRC

Simply Wall St.

4 months ago

AtriCure, Inc. (NASDAQ:ATRC) Shares Could Be 26% Below Their Intrinsic Value Estimate

AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference
ATRC

Business Wire

4 months ago

AtriCure to Participate in the Piper Sandler 36th Annual Healthcare Conference

AtriCure to Participate in the Stifel 2024 Healthcare Conference
ATRC

Business Wire

5 months ago

AtriCure to Participate in the Stifel 2024 Healthcare Conference

US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results
ATRC

Simply Wall St.

5 months ago

US$42.67 - That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After These Results

AtriCure Third Quarter 2024 Earnings: Beats Expectations
ATRC

Simply Wall St.

5 months ago

AtriCure Third Quarter 2024 Earnings: Beats Expectations

ATRC

MT Newswires

5 months ago

UBS Adjusts Price Target on AtriCure to $40 From $35, Maintains Buy Rating

ATRC

Thomson Reuters StreetEvents

5 months ago

Q3 2024 AtriCure Inc Earnings Call

AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges
ATRC

GuruFocus.com

5 months ago

AtriCure Inc (ATRC) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Market Challenges

AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
ATRC

Zacks

5 months ago

AtriCure (ATRC) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates
ATRC

Zacks

5 months ago

AtriCure (ATRC) Reports Q3 Loss, Tops Revenue Estimates

ATRC

Associated Press Finance

5 months ago

AtriCure: Q3 Earnings Snapshot

AtriCure Reports Third Quarter 2024 Financial Results
ATRC

Business Wire

5 months ago

AtriCure Reports Third Quarter 2024 Financial Results

AtriCure to Participate in the UBS Global Healthcare Conference
ATRC

Business Wire

5 months ago

AtriCure to Participate in the UBS Global Healthcare Conference

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device
ATRC

Zacks

6 months ago

AtriCure's Stock Rises After Launch of cryoSPHERE MAX Device

AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management
ATRC

Business Wire

6 months ago

AtriCure Announces Launch of cryoSPHERE MAX™ Probe for Post-Operative Pain Management

Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago
ATRC

Simply Wall St.

6 months ago

Shareholders in AtriCure (NASDAQ:ATRC) are in the red if they invested three years ago

AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe
ATRC

Zacks

6 months ago

AtriCure Gets CE Mark for EnCompass Clamp, Expands in Europe

AtriCure to Announce Third Quarter 2024 Financial Results
ATRC

Business Wire

6 months ago

AtriCure to Announce Third Quarter 2024 Financial Results

ATRC

MT Newswires

6 months ago

AtriCure Granted CE Mark for EnCompass Clamp

AtriCure Receives CE-Mark for the EnCompass® Clamp
ATRC

Business Wire

6 months ago

AtriCure Receives CE-Mark for the EnCompass® Clamp

Here’s Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC)
ATRC

Insider Monkey

7 months ago

Here’s Why TimesSquare Capital U.S. Small Cap Growth Strategy Decided to Sell AtriCure (ATRC)

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?
ATRC

Simply Wall St.

7 months ago

Is It Time To Consider Buying AtriCure, Inc. (NASDAQ:ATRC)?

AtriCure's Shares Likely to Benefit From New AtriClip Device Sales
ATRC

Zacks

7 months ago

AtriCure's Shares Likely to Benefit From New AtriClip Device Sales

AtriClip FLEX-Mini device treatment begins with first patient
ATRC

Medical Device Network

7 months ago

AtriClip FLEX-Mini device treatment begins with first patient

AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device
ATRC

Business Wire

7 months ago

AtriCure Announces that the First Patient has been Treated with the Revolutionary AtriClip® FLEX-Mini™ Device

AtriCure's (ATRC) AtriClip Receives Expanded CE-Mark Indication
ATRC

Zacks

7 months ago

AtriCure's (ATRC) AtriClip Receives Expanded CE-Mark Indication

ATRC

MT Newswires

7 months ago

AtriCure Says it Has Received Expanded Indication for AtriClip in Europe

AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation
ATRC

Business Wire

7 months ago

AtriCure Receives Expanded CE-Mark Indication for AtriClip® Devices for the Reduction of Stroke in Patients with Atrial Fibrillation

Undervalued Small Caps In United States With Insider Action For August 2024
ATRC

Simply Wall St.

7 months ago

Undervalued Small Caps In United States With Insider Action For August 2024

Exploring 3 Undervalued Small Caps With Insider Buying To Enhance Your Portfolio
ATRC

Simply Wall St.

7 months ago

Exploring 3 Undervalued Small Caps With Insider Buying To Enhance Your Portfolio

Discover 3 Undervalued Small Caps In The United States With Insider Buying
ATRC

Simply Wall St.

7 months ago

Discover 3 Undervalued Small Caps In The United States With Insider Buying

Discover 3 Undervalued Small Caps With Insider Action To Enhance Your Portfolio
ATRC

Simply Wall St.

8 months ago

Discover 3 Undervalued Small Caps With Insider Action To Enhance Your Portfolio

Top Undervalued Small Caps With Insider Action In United States August 2024
ATRC

Simply Wall St.

8 months ago

Top Undervalued Small Caps With Insider Action In United States August 2024

Top 3 Undervalued Small Caps With Insider Buys To Watch In United States August 2024
ATRC

Simply Wall St.

8 months ago

Top 3 Undervalued Small Caps With Insider Buys To Watch In United States August 2024

3 Undervalued Small Caps In United States With Insider Buying To Enhance Your Portfolio
ATRC

Simply Wall St.

8 months ago

3 Undervalued Small Caps In United States With Insider Buying To Enhance Your Portfolio

US$39.89: That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After Its Latest Results
ATRC

Simply Wall St.

8 months ago

US$39.89: That's What Analysts Think AtriCure, Inc. (NASDAQ:ATRC) Is Worth After Its Latest Results

AtriCure Second Quarter 2024 Earnings: EPS Misses Expectations
ATRC

Simply Wall St.

8 months ago

AtriCure Second Quarter 2024 Earnings: EPS Misses Expectations

ATRC

MT Newswires

8 months ago

Needham Adjusts AtriCure's Price Target to $34 From $40, Keeps Buy Rating

ATRC

MT Newswires

8 months ago

AtriCure's Q2 Adjusted Loss Widens, Revenue Rises

AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say
ATRC

Zacks

8 months ago

AtriCure (ATRC) Reports Q2 Earnings: What Key Metrics Have to Say

AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates
ATRC

Zacks

8 months ago

AtriCure (ATRC) Reports Q2 Loss, Lags Revenue Estimates

ATRC

Associated Press Finance

8 months ago

AtriCure: Q2 Earnings Snapshot

AtriCure Reports Second Quarter 2024 Financial Results
ATRC

Business Wire

8 months ago

AtriCure Reports Second Quarter 2024 Financial Results

AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference
ATRC

Business Wire

8 months ago

AtriCure to Participate in the Canaccord Genuity 44th Annual Global Growth Conference

AtriCure (ATRC) Gains China Approval for AtriClip LAA System
ATRC

Zacks

8 months ago

AtriCure (ATRC) Gains China Approval for AtriClip LAA System

ATRC

MT Newswires

8 months ago

AtriCure Receives Regulatory Nod for AtriClip Heart-Surgery Device in China

AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China
ATRC

Business Wire

8 months ago

AtriCure Receives Regulatory Approval to Sell AtriClip® Devices in China

AtriCure to Announce Second Quarter 2024 Financial Results
ATRC

Business Wire

9 months ago

AtriCure to Announce Second Quarter 2024 Financial Results

AtriCure And Two Other Undervalued Small Caps With Insider Actions In The United States
ATRC

Simply Wall St.

9 months ago

AtriCure And Two Other Undervalued Small Caps With Insider Actions In The United States

AtriCure Leads Three Undervalued Small Caps With Insider Actions In United States
ATRC

Simply Wall St.

9 months ago

AtriCure Leads Three Undervalued Small Caps With Insider Actions In United States

Exploring Three Undervalued Small Caps With Insider Action In The Region
ATRC

Simply Wall St.

9 months ago

Exploring Three Undervalued Small Caps With Insider Action In The Region

Exploring Undervalued Small Caps With Insider Buying In The United States June 2024
ATRC

Simply Wall St.

9 months ago

Exploring Undervalued Small Caps With Insider Buying In The United States June 2024

AtriCure Leads Three Undervalued Small Caps With Insider Actions In The United States
ATRC

Simply Wall St.

9 months ago

AtriCure Leads Three Undervalued Small Caps With Insider Actions In The United States

Exploring Undervalued Small Caps With Insider Actions In The United States June 2024
ATRC

Simply Wall St.

9 months ago

Exploring Undervalued Small Caps With Insider Actions In The United States June 2024

AtriCure (ATRC) Stock Slipped on Competition Threat
ATRC

Insider Monkey

9 months ago

AtriCure (ATRC) Stock Slipped on Competition Threat

June 2024 Insight On Undervalued Small Caps With Insider Transactions
ATRC

Simply Wall St.

9 months ago

June 2024 Insight On Undervalued Small Caps With Insider Transactions

Is AtriCure, Inc. (NASDAQ:ATRC) Trading At A 48% Discount?
ATRC

Simply Wall St.

10 months ago

Is AtriCure, Inc. (NASDAQ:ATRC) Trading At A 48% Discount?

Insider Buying: Chief Technical Officer Salvatore Privitera Acquires Shares of AtriCure Inc (ATRC)
ATRC

GuruFocus.com

10 months ago

Insider Buying: Chief Technical Officer Salvatore Privitera Acquires Shares of AtriCure Inc (ATRC)

AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference
ATRC

Business Wire

a year ago

AtriCure to Participate in the 2024 Leerink Partners Healthcare Crossroads Conference

AtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price Target
ATRC

Simply Wall St.

a year ago

AtriCure, Inc. (NASDAQ:ATRC) Just Reported, And Analysts Assigned A US$47.33 Price Target

The past three years for AtriCure (NASDAQ:ATRC) investors has not been profitable
ATRC

Simply Wall St.

a year ago

The past three years for AtriCure (NASDAQ:ATRC) investors has not been profitable

AtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
ATRC

Simply Wall St.

a year ago

AtriCure First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript
ATRC

Insider Monkey

a year ago

AtriCure, Inc. (NASDAQ:ATRC) Q1 2024 Earnings Call Transcript

ATRC

MT Newswires

a year ago

Needham Lowers AtriCure's PT to $40 From $46 Due to Peer Multiple Contraction, Keeps Buy Rating

ATRC

GuruFocus.com

a year ago

AtriCure Inc (ATRC) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...

Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics
ATRC

Zacks

a year ago

Compared to Estimates, AtriCure (ATRC) Q1 Earnings: A Look at Key Metrics

AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses
ATRC

GuruFocus.com

a year ago

AtriCure Inc (ATRC) Surpasses Revenue Estimates in Q1 2024 Despite Wider Losses

AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates
ATRC

Zacks

a year ago

AtriCure (ATRC) Reports Q1 Loss, Tops Revenue Estimates

ATRC

Associated Press Finance

a year ago

AtriCure: Q1 Earnings Snapshot

AtriCure Reports First Quarter 2024 Financial Results
ATRC

Business Wire

a year ago

AtriCure Reports First Quarter 2024 Financial Results

AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference
ATRC

Business Wire

a year ago

AtriCure to Participate in the 2024 Bank of America Securities Healthcare Conference

ATRC

MT Newswires

a year ago

--Oppenheimer Upgrades AtriCure to Outperform, Price Target at $32

AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management
ATRC

Zacks

a year ago

AtriCure's (ATRC) cryoSPHERE+ Probe to Aid in Pain Management

AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management
ATRC

Business Wire

a year ago

AtriCure Announces Launch of the cryoSPHERE®+ Probe for Post-Operative Pain Management

AtriCure to Announce First Quarter 2024 Financial Results
ATRC

Business Wire

a year ago

AtriCure to Announce First Quarter 2024 Financial Results

AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference
ATRC

Business Wire

a year ago

AtriCure to Participate in the 23rd Annual Needham Virtual Healthcare Conference

AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug
ATRC

Insider Monkey

a year ago

AtriCure (ATRC) Declined due to Concerns Over Anti-Obesity Drug

Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)
ATRC

GuruFocus.com

a year ago

Chief Legal Officer Karl Dahlquist Sells 8,231 Shares of AtriCure Inc (ATRC)

Share on Social Networks: